Company intelligence / Profile preview

Tomorrow London

London, Ontario, Canadatomorrowltd.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biosa Technologies has developed a recyclable, compostable mask material that blocks virus particles even when wet. The company is scaling up production with support from the Ontario government and expanding into additional applications such as HVAC filters and non-toxic pesticides. No clinical trial data reported; focus is on manufacturing and product development rather than therapeutics.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceMaterial scienceSmall molecule
Industry: Chemicals & Materials

Partnerships

Ontario provincial government funding/supportlocal agricultural groups for biomass sourcing

Beyond the preview

Go deeper on Tomorrow London.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tomorrow London.

Explore the full profile